oseen · source-linked reporting

The U.S. Food and Drug Administration clears the Fujirebio Lumipulse for distribution, the first blood test

Tornado outbreak sequence of May 15–16, 2025 — The U.S. Food and Drug Administration clears the Fujirebio Lumipulse for distribution, the first blood test that can be used to diagnose Alzheimer's disease in people 55 years or o

Published May 16, 2025· Updated October 28, 2026·1 min read

Context: Tornado outbreak sequence of May 15–16, 2025.

The U.S. Food and Drug Administration clears the Fujirebio Lumipulse for distribution, the first blood test that can be used to diagnose Alzheimer's disease in people 55 years or older with memory problems by detecting amyloid plaques. Alzheimer's can currently only be diagnosed using a PET scan. [https://www.npr.org/sections/shots-health-news/2025/05/21/nx-s1-5403736/first-fda-alzheimers-blood-test-cleared-diagnosis (NPR)] [https://www.fda.gov/news-events/press-announcements/fda-clears-first-blood-test-used-diagnosing-alzheimers-disease (FDA)]

Event summary via Wikipedia Current Events (2025-05-16).